A Leukemia Survivor’s Journey Through Transplant and Recovery

Amanda Ferraro sat down for an interview with CURE to share her experience from an initial leukemia diagnosis through intensive treatment and into long-term survivorship following a stem cell transplant.

During the conversation, she discusses the onset of her symptoms and the abrupt transition into a cancer diagnosis, emphasizing the emotional shock and uncertainty that often accompany hematologic malignancies. She explains how quickly treatment decisions needed to be made, including the initiation of chemotherapy and the eventual determination that a transplant represented the most appropriate course of action for her disease.

The transplant process is presented as a rigorous and multifaceted intervention that extends beyond the procedure itself. Amanda describes prolonged hospitalization, strict infection precautions and separation from daily routines and support networks. The reliance on donor cells introduced an additional layer of complexity, highlighting the importance of donor registries and the role of compatible matches in treatment success. Although transplantation offered curative potential, she underscores that it was not an endpoint, but rather a transition into a new and often uncertain phase of care.

Recovery following transplant is described as gradual and nonlinear. Physical healing required months of adjustment, with persistent fatigue, reduced stamina and frequent medical follow-up shaping her daily life. The emotional dimension of recovery proved equally significant, as Amanda processed the impact of her diagnosis and adapted to a redefined sense of normalcy.

She reflects on how survivorship reshaped her priorities, relationships and long-term outlook. There is a deeper appreciation for time, health and personal connections, alongside an acknowledgment of ongoing uncertainty. Amanda also emphasizes the importance of support systems and patient education.

Ultimately, she highlights the complexity of life after leukemia treatment, reinforcing that survivorship is an evolving process requiring resilience, adaptability, and continued engagement with care.

You can read more from Amanda’s conversation with CURE here!

Disclosures: Amanda is a paid Sanofi spokesperson and was engaged to share her story with chronic GVHD, but individual experiences may vary.

Transcript has been edited for clarity and conciseness.

For more news on cancer updates, research and education,  don’t forget to subscribe to CURE®’s newsletters here.